Oral cholesterol-lowering peptide approved after a decade in development

The US Food and Drug Administration (FDA) has approved Merck & Cos Lipfendra (enlicitide) to reduce levels of bad low-density lipoproteincholesterol (LDL-C). The macrocyclic peptide is the first …